Stockreport

Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

Monopar Therapeutics Inc.  (MNPR) 
PDF Trial launch in Europe coincides with the Company’s upcoming presentation at the European Society for Medical Oncology Congress WILMETTE, Ill., Sept. 13, 2021 (GLOBE [Read more]